Related Experiment Video

Updated: Jul 3, 2026

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
09:03

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

Published on: June 30, 2023

Molecular mechanisms and therapeutic development of angiogenesis inhibitors

Yihai Cao1

  • 1Laboratory of Angiogenesis Research, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Advances in Cancer Research
|July 16, 2008
PubMed

Insights

Antiangiogenic drugs like bevacizumab (Avastin) and endostatin show promise in cancer therapy. Further research into their mechanisms is vital for developing more effective cancer treatments.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Angiogenesis is crucial for tumor growth and metastasis.
  • Antiangiogenic drugs target tumor blood vessel formation.
  • Bevacizumab (Avastin) and endostatin are examples of approved antiangiogenic therapies.

Purpose of the Study:

  • To review the mechanisms of tumor angiogenesis.
  • To discuss the actions of antiangiogenic molecules in cancer therapy.
  • To highlight the need for deeper understanding of these mechanisms for drug development.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Analysis of signaling pathways involved in angiogenesis.
  • Discussion of therapeutic strategies combining antiangiogenic agents and chemotherapy.

Main Results:

  • Hundreds of antiangiogenic molecules are under investigation.
  • The precise mechanisms of survival advantage from combined therapies are not fully elucidated.
  • Understanding these mechanisms is key to optimizing antiangiogenic treatments.

Conclusions:

  • Antiangiogenic therapy represents a significant advancement in cancer treatment.
  • Further research is essential to fully understand and exploit the potential of antiangiogenic drugs.
  • Developing more potent anticancer drugs requires a deeper mechanistic insight into angiogenesis and therapeutic interventions.

More Related Videos

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia07:48

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia

Published on: June 8, 2019

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: